US Supreme Court Restores Broad Access to Abortion Pill Mifepristone
On Monday, the US Supreme Court reinstated extensive access to the abortion pill mifepristone, halting a ruling that could have disrupted medication abortion across the country. An order signed by Justice Samuel Alito permits women to acquire the pill at pharmacies or via mail without needing to see a doctor in person. These guidelines had been standard for years until a federal appeals court introduced new limitations last week. Currently, most abortions in the US are medication-based, primarily involving mifepristone and misoprostol. Their accessibility has lessened the effects of abortion restrictions in Republican-led states after the Supreme Court's 2022 decision that overturned Roe v. Wade. Louisiana had filed a lawsuit to limit mifepristone, claiming its presence conflicted with the state's ban.
Key facts
- US Supreme Court restored broad access to mifepristone on Monday.
- Justice Samuel Alito signed the order.
- The order blocks a federal appeals court ruling that had imposed new restrictions.
- Women can now obtain mifepristone at pharmacies or by mail without an in-person doctor visit.
- Most US abortions are medication-based, using mifepristone and misoprostol.
- The 2022 Supreme Court ruling overturned Roe v. Wade, allowing state bans.
- Louisiana sued to restrict mifepristone, claiming it undermined the state's ban.
- The availability of medication abortion has blunted the impact of abortion bans in Republican-led states.
Entities
Institutions
- US Supreme Court
- Alamo Women's Clinic
- Reuters
Locations
- United States
- Louisiana
- Carbondale
- Illinois